Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8297976 | 0.78 | EPHX2 (0.47) | ALDH1A1EPHX2SMN1; SMN2MEN1KMT2A | |
| SCHEMBL5490339 | 0.65 | ADH1B (0.39) | SMN1; SMN2CTSSMEN1KMT2ATSHR | |
| SCHEMBL5497103 | 0.64 | KDM4E (0.36) | ALDH1A1SMN1; SMN2CTSSMEN1KMT2A | |
| SCHEMBL7862909 | 0.64 | PPID (0.43) | ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL23023223 | 0.63 | MEN1 (0.71) | ALDH1A1EPHX2SMN1; SMN2MEN1KMT2A | |
| SCHEMBL1549048 | 0.63 | MEN1 (0.71) | ALDH1A1EPHX2SMN1; SMN2MEN1KMT2A | |
| SCHEMBL17598268 | 0.63 | MEN1 (0.71) | ALDH1A1EPHX2SMN1; SMN2MEN1KMT2A | |
| SCHEMBL23023180 | 0.62 | KMT2A (0.45) | ALDH1A1EPHX2SMN1; SMN2MEN1KMT2A | |
| SCHEMBL21401959 | 0.62 | IDO1 (0.35) | — | |
| SCHEMBL13560929 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1658066-B9 | ADAMANTYLGLYCINE- BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FOR THE TREATMENT OF DIABETES | BRISTOL MYERS SQUIBB CO (US) | 2010-02-24 | — | — | EP | disclosed |